Evogene (EVGN) Market Capitalization (2012 - 2026)

Evogene has disclosed Market Capitalization across 15 years of filings, most recently posting $3.8 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 54.0% year-over-year to $3.8 million; the TTM figure through Jun 2026 stood at $3.8 million (down 54.0% YoY), while the FY2025 annual figure was $9.6 million, down 21.28% from the prior year.
• Market Capitalization came in at $3.8 million for Q2 2026 at Evogene, down from $6.7 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $53.5 million in Q1 2022 to a low of $3.8 million in Q2 2026.
• Average Market Capitalization over 5 years is $23.8 million, with a median of $25.1 million recorded in 2023.
• Year-over-year, Market Capitalization soared 47.12% in 2023 and sank 78.54% in 2025.
• Over 5 years, Market Capitalization stood at $28.9 million in 2022, then surged by 47.12% to $42.5 million in 2023, then sank by 71.33% to $12.2 million in 2024, then declined by 21.28% to $9.6 million in 2025, then plunged by 60.0% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $3.8 million in Q2 2026, $6.7 million in Q1 2026, and $9.6 million in Q4 2025.